Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2025 ∙ WHO

WHO position paper on Pneumococcal conjugate vaccines in infants and children aged <5 years – September 2025

  • Position paper
  • Pneumococcal disease
Download:
2025 ∙ UNITAG

Compilation of the Uganda National Immunisation Technical Advisory Group reports for the period 2023-2025

  • Recommendation
  • Africa
  • Uganda
  • Human papillomavirus (HPV)
  • Typhoid
  • Malaria
  • Pneumococcal disease
  • Ebola
Download:
2025

Vaccination against pneumococcal disease in adults (revision 2025)

  • Recommendation
  • Europe
  • Belgium
  • Pneumococcal disease
Download:
2025 ∙ SAGE

SAGE Evidence to Recommendation Framework: Reduced-dose (1p+1) schedules

  • Evidence to recommendation table
  • Pneumococcal disease
Download:
2025 ∙ SAGE

SAGE Evidence to Recommendation Framework: Multi-age cohort PCV campaigns

  • Evidence to recommendation table
  • Pneumococcal disease
Download:
2025 ∙ SAGE

SAGE Evidence to Recommendation Framework: Extended-valency PCVs

  • Evidence to recommendation table
  • Pneumococcal disease
Download:
2025 ∙ SAGE

Meeting of the Strategic Advisory Group of Experts on Immunization, March 2025: Conclusions and recommendations

  • Meeting report
  • Pneumococcal disease
  • Mpox
  • Herpes zoster
  • Poliomyelitis
Download:
2024 ∙ Silverii, G. A. Gabutti, G. Tafuri, S. Sarti, F. Pratesi, A. Clerico, A. Fornengo, R. Greco, C. Irace, C. Sordi, V. Sorice, G. P. Cavallo, M. Ponziani, M. C. Mannucci, E. Dicembrini, I.

Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies

  • Adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2024 ∙ Gebreyesus, A. Tesfay, K.

Effect of maternal education on completing childhood vaccination in Ethiopia: systematic review and meta-analysis

  • Africa
  • Ethiopia
  • Children
  • Tuberculosis
  • Poliomyelitis
  • Diphtheria
  • Tetanus
  • Hepatitis B
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Sepúlveda-Pachón, I. T. Dunne, E. M. Hanquet, G. Baay, M. Menon, S. Jodar, L. Gessner, B. D. Theilacker, C.

Effect of pneumococcal conjugate vaccines on viral respiratory infections: a systematic literature review

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
Loading...